These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12552349)

  • 1. Acetylcholine muscarinic receptors and response to anti-cholinesterase therapy in patients with Alzheimer's disease.
    Brown D; Chisholm JA; Owens J; Pimlott S; Patterson J; Wyper D
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):296-300. PubMed ID: 12552349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficits in iodine-labelled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease.
    Wyper DJ; Brown D; Patterson J; Owens J; Hunter R; Teasdale E; McCulloch J
    Eur J Nucl Med; 1993 May; 20(5):379-86. PubMed ID: 8519256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised placebo controlled study to assess the effects of cholinergic treatment on muscarinic receptors in Alzheimer's disease.
    Kemp PM; Holmes C; Hoffmann S; Wilkinson S; Zivanovic M; Thom J; Bolt L; Fleming J; Wilkinson DG
    J Neurol Neurosurg Psychiatry; 2003 Nov; 74(11):1567-70. PubMed ID: 14617718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPET imaging of central muscarinic receptors with (R,R)[123I]-I-QNB: methodological considerations.
    Norbury R; Travis MJ; Erlandsson K; Waddington W; Owens J; Ell PJ; Murphy DG
    Nucl Med Biol; 2004 Jul; 31(5):583-90. PubMed ID: 15219276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional covariance of muscarinic acetylcholine receptors in Alzheimer's disease using (R, R) [(123)I]-QNB SPECT.
    Colloby SJ; McKeith IG; Wyper DJ; O'Brien JT; Taylor JP
    J Neurol; 2015 Sep; 262(9):2144-53. PubMed ID: 26122542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic acetylcholine receptor status in Alzheimer's disease assessed using (R, R) 123I-QNB SPECT.
    Pakrasi S; Colloby SJ; Firbank MJ; Perry EK; Wyper DJ; Owens J; McKeith IG; Williams ED; O'Brien JT
    J Neurol; 2007 Jul; 254(7):907-13. PubMed ID: 17361343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease.
    Piggott MA; Owens J; O'Brien J; Colloby S; Fenwick J; Wyper D; Jaros E; Johnson M; Perry RH; Perry EK
    J Chem Neuroanat; 2003 Mar; 25(3):161-73. PubMed ID: 12706204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomography.
    Holman BL; Gibson RE; Hill TC; Eckelman WC; Albert M; Reba RC
    JAMA; 1985 Dec; 254(21):3063-6. PubMed ID: 3877181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the neural effect of switching from donepezil to galantamine based on single-photon emission computed tomography findings in patients with Alzheimer's disease.
    Oka M; Nakaaki S; Negi A; Miyata J; Nakagawa A; Hirono N; Mimura M
    Psychogeriatrics; 2016 Mar; 16(2):121-34. PubMed ID: 26114924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
    Nobili F; Koulibaly M; Vitali P; Migneco O; Mariani G; Ebmeier K; Pupi A; Robert PH; Rodriguez G; Darcourt J
    J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a high dosage of donepezil for Alzheimer's disease as examined by single-photon emission computed tomography imaging.
    Kanaya K; Abe S; Sakai M; Fujii H; Koizumi K; Iwamoto T
    Psychogeriatrics; 2012 Sep; 12(3):172-8. PubMed ID: 22994615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in GTP-sensitive high affinity agonist binding of muscarinic acetylcholine receptors in autopsied brains of dementia with Lewy bodies and Alzheimer's disease.
    Shiozaki K; Iseki E
    J Neurol Sci; 2004 Aug; 223(2):145-8. PubMed ID: 15337615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the in vivo rat brain regional pharmacokinetics of [3H]QNB, (R,S)-[125I]-4IQNB, and (R,R)-[125I]-4IQNB binding to the muscarinic acetylcholine receptor in relationship to the regional subtype composition.
    Boulay SF; Gitler MS; Sood VK; Cohen VI; Zeeberg BR; Reba RC
    Receptor; 1995; 5(4):207-18. PubMed ID: 8840399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic and perfusion brain networks in Parkinson disease dementia.
    Colloby SJ; McKeith IG; Burn DJ; Wyper DJ; O'Brien JT; Taylor JP
    Neurology; 2016 Jul; 87(2):178-85. PubMed ID: 27306636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boronic acid adducts of technetium dioxime (BATO) complexes derived from quinuclidine benzilate (QNB) boronic acid stereoisomers: syntheses and studies of their binding to the muscarinic acetylcholine receptor.
    Jurisson SS; Pirro J; DiRocco RJ; Rosenspire KC; Jagoda E; Nanjappan P; Eckelman WC; Nowotnik DP; Nunn AD
    Nucl Med Biol; 1995 Apr; 22(3):269-81. PubMed ID: 7627141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodo-QNB cortical binding and brain perfusion: effects of a cholinergic basal forebrain lesion in the rat.
    Sorger D; Kämpfer I; Schliebs R; Rossner S; Dannenberg C; Knapp WH
    Nucl Med Biol; 1999 Jan; 26(1):9-16. PubMed ID: 10096495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the rCBF images of patients with Alzheimer's disease receiving Donepezil therapy.
    Staff RT; Gemmell HG; Shanks MF; Murray AD; Venneri A
    Nucl Med Commun; 2000 Jan; 21(1):37-41. PubMed ID: 10717900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of response to donepezil in Alzheimer's disease: combined MRI analysis of the substantia innominata and SPECT measurement of cerebral perfusion.
    Kanetaka H; Hanyu H; Hirao K; Shimizu S; Sato T; Akai T; Iwamoto T; Koizumi K
    Nucl Med Commun; 2008 Jun; 29(6):568-73. PubMed ID: 18458605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
    Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of novel tacrine-related cholinesterase inhibitors in the reversal of 3-quinuclidinyl benzilate-induced cognitive deficit in rats--Is there a potential for Alzheimer's disease treatment?
    Misik J; Korabecny J; Nepovimova E; Kracmarova A; Kassa J
    Neurosci Lett; 2016 Jan; 612():261-268. PubMed ID: 26708634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.